Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
Shakila Meshkat, Kayla M. Teopiz, Joshua D. Di Vincenzo, Julia Bailey, Joshua D. Rosenblat, Roger Ho, Taeho Greg Rhee, Felicia Ceban, Angela T.H. Kwan, Bing Cao, Roger S. McIntyre
Topics & Concepts
Major depressive disorderAntidepressantGABAA receptorDepression (economics)Adverse effectBipolar disorderPsychologyPsychiatryDiscontinuationAnhedoniaMedicineNeuroscienceInternal medicineMoodAnxietyReceptorSchizophrenia (object-oriented programming)EconomicsMacroeconomicsNeuroscience and Neuropharmacology ResearchTreatment of Major DepressionTryptophan and brain disorders